Sign up to save your podcasts
Or
Share HCP Roundtable: Improving Clinician-Patient Conversations in Lung Cancer Biomarker Testing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HCP Roundtable: Improving Clinician-Patient Conversations in Lung Cancer Biomarker Testing
Comprehensive biomarker testing can play a very important role in the personalized treatment for patients with non-small cell lung cancer (NSCLC). How do we improve clinician-patient conversations in biomarker testing? And how do we remove barriers that can impede an HCP’s ability to treat patients with personalized care?
Dr. Heather Wakelee, Professor of Medicine and Chief of the Division of Oncology at Stanford University School of Medicine and Dr. Leigh Boehmer, medical director at Association of Community Cancer Centers (ACCC) weigh in on this very important topic.
See More from the Empowered! Podcast
View all episodes
By Patient Empowerment Network
5
11 ratings
Comprehensive biomarker testing can play a very important role in the personalized treatment for patients with non-small cell lung cancer (NSCLC). How do we improve clinician-patient conversations in biomarker testing? And how do we remove barriers that can impede an HCP’s ability to treat patients with personalized care?
Dr. Heather Wakelee, Professor of Medicine and Chief of the Division of Oncology at Stanford University School of Medicine and Dr. Leigh Boehmer, medical director at Association of Community Cancer Centers (ACCC) weigh in on this very important topic.
See More from the Empowered! Podcast